ARTICLE | Clinical News
Inovio preclinical data
February 13, 2012 8:00 AM UTC
Inovio Pharmaceuticals Inc. (NYSE-A:INO), Blue Bell, Pa. Product: SynCon Type B influenza DNA vaccine Business: Infectious Indication: Vaccinate against Type B influenza virus infection In mice, Inov...